Connect with us

Technology

ASE Technology Holding Co., Ltd. Reports Its Unaudited Consolidated Financial Results for the Third Quarter of 2024

Published

on

TAIPEI, Oct. 31, 2024 /PRNewswire/ — ASE Technology Holding Co., Ltd. (TWSE: 3711, NYSE: ASX) (“We”, “ASEH”, or the “Company”), the leading provider of semiconductor assembly and testing services (“ATM”) and the provider of electronic manufacturing services (“EMS”), today reported its unaudited net revenues[1] of NT$160,105 million for 3Q24, up by 3.9% year-over-year and up by 14.2% sequentially. Net income attributable to shareholders of the parent for the quarter totaled NT9,666 million, up from NT$8,776 million in 3Q23 and up from NT$7,778 million in 2Q24.  Basic earnings per share for the quarter were NT$2.24 (or US$0.138 per ADS), compared to NT$2.04 for 3Q23 and NT$1.80 for 2Q24. Diluted earnings per share for the quarter were NT$2.17 (or US$0.134 per ADS), compared to NT$2.00 for 3Q23 and NT$1.75 for 2Q24.

As of September 30, 2024, we have completed the PPA and have retrospectively adjusted the consolidated financial results for prior period.

RESULTS OF OPERATIONS

3Q24 Results Highlights – Consolidated

Net revenues from packaging operations, testing operations, EMS operations, and others represented approximately 43%, 9%, 47%, and 1% of the total net revenues for the quarter, respectively.Cost of revenues was NT$133,673 million for the quarter, up from NT$117,184 million in 2Q24.Raw material cost totaled NT$84,658 million for the quarter, representing 53% of the total net revenues.Labor cost totaled NT$16,468 million for the quarter, representing 10% of the total net revenues.Depreciation, amortization and rental expenses totaled NT$13,647 million for the quarter.Gross margin increased by 0.1 percentage points to 16.5% in 3Q24 from 16.4% in 2Q24.Operating margin was 7.2% in 3Q24, compared to 6.4% in 2Q24.In terms of non-operating items:Net interest expense was NT$1,291 million.Net foreign exchange gain was NT$1,890 million, primarily attributable to the depreciation of the U.S. dollar against the New Taiwan dollar.Net loss on valuation of financial assets and liabilities was NT$943 million.Net gain on equity-method investments was NT$485 million.Other net non-operating income was NT$643 million, primarily attributable to miscellaneous income.
Total non-operating income and expenses for the quarter was NT$784 million.Income before tax was NT$12,260 million in 3Q24, compared to NT$10,105 million in 2Q24. We recorded income tax expenses of NT$2,054 million for the quarter, compared to NT$1,950 million in 2Q24.Net income attributable to shareholders of the parent was NT$9,666 million in 3Q24, compared to NT$8,776 million in 3Q23 and NT$7,778 million in 2Q24.Our total number of shares outstanding at the end of the quarter was 4,412,064,337, including treasury stock owned by our subsidiaries in 3Q24. Our 3Q24 basic earnings per share of NT$2.24 (or US$0.138 per ADS) were based on 4,321,735,473 weighted average numbers of shares outstanding in 3Q24. Our 3Q24 diluted earnings per share of NT$2.17 (or US$0.134 per ADS) were based on 4,391,466,234 weighted average number of shares outstanding in 3Q24.

3Q24 Results Highlights – ATM

Net revenues were NT$85,790 million for the quarter, up by 2.5% year-over-year and up by 10.3% sequentially.Cost of revenues was NT$65,989 million for the quarter, up by 1.4% year-over-year and up by 8.9% sequentially.Raw material cost totaled NT$24,177 million for the quarter, representing 28% of the total net revenues.Labor cost totaled NT$13,309 million for the quarter, representing 16% of the total net revenues.Depreciation, amortization and rental expenses totaled NT$12,163 million for the quarter.Gross margin increased by 1.0 percentage points to 23.1% in 3Q24 from 22.1% in 2Q24.Operating margin was 10.8% in 3Q24, compared to 9.3% in 2Q24.

3Q24 Results Highlights – EMS

Net revenues were NT$75,384 million, up by 6.2% year-over-year and up by 19.8% sequentially.Cost of revenues for the quarter was NT$68,627 million, up by 6.4% year-over-year and up by 20.6% sequentially.Raw material cost totaled NT$60,912 million for the quarter, representing 81% of the total net revenues.Labor cost totaled NT$3,051 million for the quarter, representing 4% of the total net revenues.Depreciation, amortization and rental expenses totaled NT$1,219 million for the quarter.Gross margin decreased by 0.6 percentage points to 9.0% in 3Q24 from 9.6% in 2Q24.Operating margin was 3.3% in 3Q24, compared to 3.1% in 2Q24.

LIQUIDITY AND CAPITAL RESOURCES

Capital expenditures in 3Q24 totaled US$603 million, of which US$312 million was used in packaging operations, US$274 million in testing operations, US$14 million in EMS operations and US$3 million in interconnect materials operations and others.Total unused credit lines amounted to NT$361,264 million as of September 30, 2024.Current ratio was 1.18 and net debt to equity ratio was 0.41 as of September 30, 2024.Total number of employees was 94,456 as of September 30, 2024, compared to 92,243 as of June 30, 2024.

BUSINESS REVIEW

Customers
ATM BASIS

Our five largest customers together accounted for approximately 46% of our total net revenues in 3Q24, compared to 45% in 2Q24. One customer accounted for more than 10% of our total net revenues in 3Q24.Our top 10 customers contributed 61% of our total net revenues in 3Q24, compared to 60% in 2Q24.Our customers that are integrated device manufacturers or IDMs accounted for 31% of our total net revenues in 3Q24, compared to 30% in 2Q24.

EMS BASIS

Our five largest customers together accounted for approximately 72% of our total net revenues in 3Q24, compared to 67% in 2Q24. One customer accounted for more than 10% of our total net revenues in 3Q24.Our top 10 customers contributed 78% of our total net revenues in 3Q24, compared to 74% in 2Q24.

About ASE Technology Holding Co., Ltd.
ASEH is the leading provider of semiconductor manufacturing services in assembly and test. The Company develops and offers complete turnkey solutions covering front-end engineering test, wafer probing and final test, as well as packaging, materials and electronic manufacturing services through USI with superior technologies, breakthrough innovations, and advanced development programs. With advanced technological capabilities and a global presence spanning Taiwan, China, South Korea, Japan, Singapore, Malaysia, Philippines, Vietnam, Mexico, and Tunisia as well as the United States and Europe, ASEH has established a reputation for reliable, high quality products and services.

For more information, please visit our website at https://www.aseglobal.com.

Safe Harbor Notice
This press release contains “forward-looking statements” within the meaning of Section 27A of the United States Securities Act of 1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Although these forward-looking statements, which may include statements regarding our future results of operations, financial condition or business prospects, are based on our own information and information from other sources we believe to be reliable, you should not place undue reliance on these forward-looking statements, which apply only as of the date of this press release. The words “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan” and similar expressions, as they relate to us, are intended to identify these forward-looking statements in this press release. These forward-looking statements are necessarily estimates reflecting the best judgment of our senior management and our actual results of operations, financial condition or business prospects may differ materially from those expressed or implied by the forward-looking statements for reasons including, among others, risks associated with cyclicality and market conditions in the semiconductor or electronic industry; changes in our regulatory environment, including our ability to comply with new or stricter environmental regulations and to resolve environmental liabilities; demand for the outsourced semiconductor packaging, testing and electronic manufacturing services we offer and for such outsourced services generally; the highly competitive semiconductor or manufacturing industry we are involved in; our ability to introduce new technologies in order to remain competitive; international business activities; our business strategy; our future expansion plans and capital expenditures; the strained relationship between the Republic of China and the People’s Republic of China; general economic and political conditions; the recent shift in United States trade policies; possible disruptions in commercial activities caused by natural or human-induced disasters; fluctuations in foreign currency exchange rates; and other factors. For a discussion of these risks and other factors, please see the documents we file from time to time with the Securities and Exchange Commission, including the 2023 Annual Report on Form 20-F filed on April 3, 2024.

Supplemental Financial Information
(Unaudited)

Consolidated Operations

3Q24

2Q24

3Q23

EBITDA[2] (NT$ million)

28,621

26,127

27,822

ATM Operations

3Q24

2Q24

3Q23

Net Revenues (NT$ million)

85,790

77,813

83,684

Revenues by Application

Communication

50 %

49 %

52 %

Computing

18 %

19 %

19 %

Automotive, Consumer & Others

32 %

32 %

29 %

Revenues by Type

Bumping, Flip Chip, WLP & SiP

45 %

44 %

44 %

Wirebonding

29 %

31 %

32 %

Others

8 %

7 %

8 %

Testing

16 %

16 %

15 %

Material

2 %

2 %

1 %

Capacity & EBITDA

CapEx[3] (US$ million)

588

374

210

EBITDA[2] (NT$ million)

24,186

22,205

23,117

Number of Wirebonders

25,373

25,154

26,215

Number of Testers

5,966

5,676

5,510

EMS Operations

3Q24

2Q24

3Q23

Net Revenues (NT$ million)

75,384

62,907

70,970

Revenues by Application

Communication

34 %

33 %

34 %

Computing

9 %

11 %

8 %

Consumer

36 %

29 %

37 %

Industrial

11 %

13 %

12 %

Automotive

9 %

11 %

7 %

Others

1 %

3 %

2 %

Capacity 

CapEx[3] (US$ million)

14

31

28

ASE Technology Holding Co., Ltd.
Summary of Consolidated Statement of Income Data
(In NT$ million, except per share data)
(Unaudited)

For the three months ended

For the nine months ended

Sep. 30

2024

Jun. 30 2024

(Retrospectively Adjusted)

Sep. 30

2023

Sep. 30

2024

Sep. 30

2023

Net revenues

Packaging

69,154

62,834

68,709

191,447

190,584

Testing

14,124

12,623

12,819

38,848

36,518

EMS

74,871

62,853

70,948

197,050

189,063

Others

1,956

1,928

1,691

5,801

5,168

Total net revenues

160,105

140,238

154,167

433,146

421,333

Cost of revenues

(133,673)

(117,184)

(129,251)

(362,839)

(355,337)

Gross profit

26,432

23,054

24,916

70,307

65,996

Operating expenses

Research and development

(7,439)

(7,106)

(6,759)

(21,154)

(18,549)

Selling, general and administrative

(7,517)

(6,939)

(6,752)

(21,191)

(18,934)

Total operating expenses

(14,956)

(14,045)

(13,511)

(42,345)

(37,483)

Operating income

11,476

9,009

11,405

27,962

28,513

Net non-operating income and expenses

Interest expense – net

(1,291)

(1,158)

(1,247)

(3,557)

(3,424)

Foreign exchange gain (loss) – net

1,890

(1,420)

(2,090)

(2,748)

(2,733)

Gain (Loss) on valuation of financial assets and liabilities – net

(943)

2,664

2,820

5,819

4,837

Gain on equity-method investments – net

485

459

656

1,001

970

Others – net

643

551

708

1,700

2,070

Total non-operating income and expenses

784

1,096

847

2,215

1,720

Income before tax

12,260

10,105

12,252

30,177

30,233

Income tax expense

(2,054)

(1,950)

(2,890)

(5,897)

(6,582)

Income from operations and before non-controlling interests

10,206

8,155

9,362

24,280

23,651

Non-controlling interests

(540)

(377)

(586)

(1,176)

(1,318)

Net income attributable to shareholders of the parent

9,666

7,778

8,776

23,104

22,333

Per share data:

Earnings per share

– Basic

NT$2.24

NT$1.80

NT$2.04

NT$5.35

NT$5.20

– Diluted

NT$2.17

NT$1.75

NT$2.00

NT$5.17

NT$5.05

Earnings per equivalent ADS

– Basic

US$0.138

US$0.112

US$0.130

US$0.335

US$0.338

– Diluted

US$0.134

US$0.109

US$0.127

US$0.324

US$0.328

Number of weighted average shares used in diluted EPS calculation ( in thousand shares)

4,391,465

4,383,325

4,347,752

4,385,913

4,346,129

FX (NTD/USD)

32.31

32.23

31.45

31.95

30.81

ASE Technology Holding Co., Ltd.
Summary of ATM Statement of Income Data
(In NT$ million) 
(Unaudited)

For the three months ended

For the nine months ended

Sep. 30

2024

Jun. 30

 2024

Sep. 30

2023

Sep. 30

2024

Sep. 30

2023

Net revenues:

Packaging

70,290

63,838

69,731

194,516

193,108

Testing

14,124

12,623

12,819

38,848

36,518

Direct Material

1,295

1,264

1,098

3,898

3,369

Others

81

88

36

250

116

Total net revenues

85,790

77,813

83,684

237,512

233,111

Cost of revenues

(65,989)

(60,612)

(65,094)

(184,952)

(183,611)

Gross profit

19,801

17,201

18,590

52,560

49,500

Operating expenses:

Research and development

(5,773)

(5,483)

(5,344)

(16,392)

(14,361)

Selling, general and administrative

(4,803)

(4,464)

(4,426)

(13,612)

(12,505)

Total operating expenses

(10,576)

(9,947)

(9,770)

(30,004)

(26,866)

Operating income

9,225

7,254

8,820

22,556

22,634

ASE Technology Holding Co., Ltd.
Summary of EMS Statement of Income Data
(In NT$ million) 
(Unaudited)

For the three months ended

For the nine months ended

Sep. 30

2024

Jun. 30 2024

(Retrospectively Adjusted)

Sep. 30

2023

Sep. 30

2024

Sep. 30

2023

Net revenues

Total net revenues

75,384

62,907

70,970

197,656

189,127

Cost of revenues

(68,627)

(56,882)

(64,500)

(179,422)

(172,451)

Gross profit

6,757

6,025

6,470

18,234

16,676

Operating expenses

Research and development

(1,668)

(1,668)

(1,453)

(4,869)

(4,304)

Selling, general and administrative

(2,636)

(2,415)

(2,250)

(7,360)

(6,191)

Total operating expenses

(4,304)

(4,083)

(3,703)

(12,229)

(10,495)

Operating income

2,453

1,942

2,767

6,005

6,181

ASE Technology Holding Co., Ltd.
Summary of Consolidated Balance Sheet Data
(In NT$ million)
(Unaudited)

As of Sep. 30, 2024

As of Jun. 30, 2024

(Retrospectively Adjusted)

Current assets

Cash and cash equivalents

71,711

66,173

Financial assets – current

6,643

9,162

Trade receivables

114,061

102,361

Inventories

68,986

63,495

Others

17,364

29,144

Total current assets

278,765

270,335

Financial assets – non-current & Investments – equity -method

42,300

30,887

Property, plant and equipment

283,447

271,870

Right-of-use assets

11,499

11,292

Intangible assets

68,038

68,316

Others

30,510

30,291

Total assets

714,559

682,991

Current liabilities

Short-term borrowings[4]

56,726

51,065

Current portion of bonds payable & Current portion of  long-term borrowings

23,531

18,655

Trade payables

82,595

70,906

Others

72,830

89,495

Total current liabilities

235,682

230,121

Bonds payable

17,073

21,976

Long-term borrowings

108,003

84,414

Other liabilities

22,748

23,053

Total liabilities

383,506

359,564

Equity attributable to shareholders of the parent

309,399

302,323

Non-controlling interests

21,654

21,104

Total liabilities & shareholders’ equity

714,559

682,991

Current ratio

1.18

1.17

Net debt to equity ratio

0.41

0.34

ASE Technology Holding Co., Ltd.
Summary of Consolidated Statement of Cash Flow Data
(In NT$ million)
(Unaudited)

        For the three months ended

For the nine months ended

Sep. 30

2024

Jun. 30 2024

(Retrospectively Adjusted)

Sep. 30

2023

Sep. 30

2024

Sep. 30

2023

Cash Flows from Operating Activities

Profit before income tax

12,260

10,105

12,252

30,177

30,233

Depreciation & amortization

15,037

14,813

14,568

44,449

43,495

Other operating activities items

(5,235)

(8,132)

(5,940)

(19,083)

(6,134)

Net cash generated from operating activities

22,062

16,786

20,880

55,543

67,594

Cash Flows from Investing Activities

Net payments for property, plant

and equipment

(19,769)

(14,786)

(14,471)

(47,068)

(41,824)

Other investment activities items

(2,593)

304

(151)

(5,284)

(2,021)

Net cash used in investing activities

(22,362)

(14,482)

(14,622)

(52,352)

(43,845)

Cash Flows from Financing Activities

Total net proceeds from (repayment of) borrowings and bonds

30,909

(12,330)

28,640

18,439

13,624

Dividends paid

(22,460)

(37,841)

(22,460)

(37,841)

Other financing activities items

(51)

(1,093)

(38)

(1,177)

(977)

Net cash generated from (used in) financing activities

8,398

(13,423)

(9,239)

(5,198)

(25,194)

Foreign currency exchange effect

(2,560)

2,187

6,443

6,434

6,478

Net increase (decrease) in cash

and cash equivalents

5,538

(8,932)

3,462

4,427

5,033

Cash and cash equivalents at the beginning of period

66,173

75,105

59,351

67,284

58,040

Cash and cash equivalents at the

end of period

71,711

66,173

62,813

71,711

63,073

Cash and cash equivalents in the consolidated balance sheet

71,711

66,173

62,812

71,711

62,812

Cash and cash equivalents included in disposal groups held for sale

1

261

 

[1] All financial information presented in this press release is unaudited, consolidated and prepared in accordance with Taiwan-IFRS (International Financial Reporting Standards as endorsed for use in the R.O.C.).  Such financial information is generated internally by us and has not been subjected to the same review and scrutiny, including internal auditing procedures and audit by our independent auditors, to which we subject our year-end audited consolidated financial statements, and may vary materially from the year-end audited consolidated financial information for the same period.  Any evaluation of the financial information presented in this press release should also take into account our published year-end audited consolidated financial statements and the notes to those statements.  In addition, the financial information presented is not necessarily indicative of our results of operations for any future period.

[2] EBITDA stands for net income or loss before interest, taxes, depreciation, amortization, impairment and investment gain or loss as well as other items.

[3] Capital expenditure excludes building construction costs.

[4] Short-term borrowings include short-term loans and bills payable.

 

Investor Relations Contact
ir@aseglobal.com
Tel: +886.2.6636.5678
https://www.aseglobal.com

View original content:https://www.prnewswire.com/news-releases/ase-technology-holding-co-ltd-reports-its-unaudited-consolidated-financial-results-for-the-third-quarter-of-2024-302292377.html

SOURCE ASE Technology Holding Co., Ltd.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Macrogen Consortium win tender for National Bio Big Data Project

Published

on

By

Illumina is proud to be selected as sequencing technology partner to the Macrogen Consortium.

SEOUL, South Korea, Dec. 23, 2024 /PRNewswire/ — Macrogen a global healthcare company that specializes in precision medicine and Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today that they are honoured to support the National Bio Big Data project by sequencing and analysing 145,952 Korean genomes.

The National Bio Big Data Project project has been running in Korea as a pilot project since 2020. During this period about 20,000 genomes were analysed, 10,000 of these including people with a rare disease. The ultimate goal is to enable precision medicine by building a reference genome for about 770,000 Koreans by 2028 and a total of 1 million by 2032.  

“Being a part of this step change to improving public health in Korea through the voluntary collection and analysis of genomic, clinical and life record information from the general public, is paramount to ensure precision medicine becomes a standard of care for all Koreans,” said Changhoon Kim, CEO Macrogen.

“Illumina is pleased to be a part of the Korean bio industry ecosystem and to participate in such an important national project. We look forward to contributing to Korea by bringing our expertise and lessons learned from our direct involvement in leading pop gen projects around the world,” said Robert McBride, General Manager of Illumina Korea.

People across the globe have very similar genes but a small number of variants between populations can impact health. For example, some variants are associated closely with particular diseases such as cystic fibrous.[1]These variants can present differently in populations and have a significant impact on how individuals respond to medicines and treatments. Therefore, it is beneficial for Koreans to have information available that is unique to them.

Worldwide, the number of pop gen projects is expanding rapidly, including the UK, Japan, Singapore, Qatar, the United Arab Emirates, and Nigeria.

“Population genome projects are growing worldwide with many programs reaching significant milestones. But despite this inequity remains with the majority of genome datasets being of European descent. This means we have a lot of information how to develop drugs for European populations but this doesn’t translate in any meaningful way to other nationalities, said Robert McBride.

Population genomics provides a platform for industry engagement and investment, specifically in the pharmaceutical, biotechnology, and data sectors. By integrating large, diverse data sets and using advanced computing technology (such as artificial intelligence or machine learning), health systems and partners are optimally positioned to unlock the power of the genome even further, while improving quality of life and care and fostering economic growth.

“Precision medicine is changing how diseases are treated and this benefits everyone. For patients, treatments often work better when decisions are based around an individual’s genome, for drug companies it can reduce cost of development and for governments there are long term savings related to less waste and healthier patients,” said Changhoon Kim.

References

[1] https://www.genome.gov/about-genomics/educational-resources/fact-sheets/human-genomic-variation#:~:text=How%20do%20peoples’%20genomes%20vary,person%20responds%20to%20certain%20medications.

About Macrogen

Macrogen is a global genetic service provider, partnered with over 18,000 scientists in 150+ countries, and with more than 20 years of experience in the industry.

Established in 1997, from the Genome Medical Research Institute of Seoul National University, Macrogen has become a major service provider and consulting agent for government agencies, universities and research institutes around the world.

About Illumina

Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. To learn more, visit www.illumina.com and connect with us on X (Twitter), Facebook, LinkedIn, Instagram, TikTok, and YouTube

About the Consortium

Macrogen Consortium members include the following companies: DNA Link, Theragen Bio, and CG Invites

View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/macrogen-consortium-win-tender-for-national-bio-big-data-project-302335981.html

SOURCE Illumina

Continue Reading

Technology

As 2025 IRS Mileage Rate Hits 70 Cents, Expert Warns: Ditch Risky Apps for Secure Paper Tracking

Published

on

By

Gig economy expert Ed Ryder warns against the risks of mileage tracking apps, and advocates using paper-based tracking methods instead. He introduces The Big Mileage Form, a secure alternative developed over two years to meet the specific needs of food delivery gig workers. Ryder highlights recent tech failures, like the July 2024 global IT outage, to underscore the vulnerabilities of digital solutions. The press release also mentions Ryder’s significant mileage deduction using his form and directs readers to GigCoach.net for additional resources, including a consumer tutorial to drive better food delivery outcomes and a gig coach training program.

PHILADELPHIA, Dec. 22, 2024 /PRNewswire-PRWeb/ — As the IRS announces a standard mileage rate of 70 cents per mile for 2025, gig economy expert Ed Ryder, who has completed over 10,000 deliveries with his own car using major food delivery platforms, urges fellow gig workers to reconsider their mileage tracking methods. While acknowledging the convenience of digital solutions, Ryder advocates for a return to secure, paper-based tracking to protect valuable mileage deductions.

With the mileage rate at 70 cents, accurate tracking is crucial for gig workers and small business owners. Mileage apps seem convenient, but they risk data loss from outages, glitches, and cyber attacks. Many overlook these significant dangers.

“With the mileage rate increasing to 70 cents, accurate tracking is more crucial than ever for gig workers and small business owners,” says Ryder, creator of The Big Mileage Form. “While mileage tracking apps seem convenient, they come with significant risks that many overlook. Network outages, app glitches, and cyber attacks can jeopardize months of data.”

Ryder points to the July 2024 global IT outage as a prime example of technology’s vulnerabilities. “A faulty software update caused mass airline disruptions and impacted other industries, catching major corporations off guard. This incident highlights that even in our digital age, software isn’t infallible. For me, I simply won’t trust mileage tracking apps with my most important tax deduction.”

To address these concerns, Ryder developed a comprehensive, paper-based solution. “I spent two years perfecting The Big Mileage Form, tailoring it to the specific needs of food delivery gig workers,” he explains. “At 11×17 inches, it provides ample space for detailed record-keeping and, crucially, it’s immune to software glitches, data breaches, and ransomware attacks.”

Ryder’s meticulous paper-based record-keeping resulted in a mileage deduction exceeding $19,000 on his 2023 federal taxes. “All my business-related miles are thoroughly documented on paper. I’m fully prepared to defend this deduction in case of an audit. This level of confidence is what I aim to provide other gig workers.”

“In today’s digital age, sometimes the most secure solution is the simplest one,” Ryder concludes. “My form not only ensures data security but also prepares users for potential IRS audits. It’s time to reconsider the old-fashioned, but reliable pen-and-paper method.”

For those interested in learning more about effective mileage tracking and other aspects of gig work, Ryder offers valuable resources on GigCoach.net. These include a tutorial for consumers titled ‘Fair Deal Delivery,’ which provides insights on how to improve food delivery outcomes. Additionally, experienced food delivery couriers can explore Ryder’s gig coach training program. Visit GigCoach.net to access these resources and learn more about The Big Mileage Form.

Media Contact

Ed Ryder, Match Experiment LLC, 1 484-493-8740, hello@ideamaned.com, gigcoach.net

View original content to download multimedia:https://www.prweb.com/releases/as-2025-irs-mileage-rate-hits-70-cents-expert-warns-ditch-risky-apps-for-secure-paper-tracking-302337779.html

SOURCE Gig economy expert Ed Ryder

Continue Reading

Technology

DATA BREACH ALERT: Edelson Lechtzin LLP Is Investigating Claims On Behalf Of Ascension Health Customers Whose Data May Have Been Compromised

Published

on

By

NEWTOWN, Pa., Dec. 22, 2024 /PRNewswire/ — The law firm of Edelson Lechtzin LLP is investigating claims regarding data privacy violations by Ascension Health (“Ascension”). Ascension learned of suspicious activity on or about May 8, 2024. To join this case, go HERE.

About Ascension Health

Ascension is a prominent non-profit health system in the nation and operates under Catholic principles.

What happened?

On or about May 8, 2024, Ascension detected unauthorized activity in its computer systems. Ascension initiated an investigation, which included retaining consulting cybersecurity experts and notifying the FBI. The investigation determined that between May 7 and 8, 2024, a cybercriminal accessed files containing personal information about Ascension’s patients and employees. This information included names, medical records, payment details, insurance information, government identification numbers, and other personal data such as dates of birth and addresses. Approximately 6 million individuals have been affected by this data breach.

How can I protect my personal data?

If you receive a data breach notification, you must guard against possible misuse of your personal information, including identity theft and fraud, by regularly reviewing your account statements and monitoring your credit reports for suspicious or unauthorized activity. Additionally, you should consider legal options for mitigating such risks.

Edelson Lechtzin LLP is investigating a class action lawsuit to seek legal remedies for customers whose sensitive personal and patient data may have been compromised by the Ascension data breach.

For more information, please contact:

Marc H. Edelson, Esq.
EDELSON LECHTZIN LLP
411 S. State Street, Suite N-300
Newtown, PA 18940
Phone: 844-696-7492
Email: medelson@edelson-law.com
Web:  www.edelson-law.com 

About Edelson Lechtzin LLP
Edelson Lechtzin LLP is a national class action law firm with offices in Pennsylvania and California. In addition to cases involving data breaches, our lawyers focus on class and collective litigation in cases alleging securities and investment fraud, violations of the federal antitrust laws, employee benefit plans under ERISA, wage theft and unpaid overtime, consumer fraud, and catastrophic injuries.

This press release may be considered Attorney Advertising in some jurisdictions. No class has been certified in this case, so counsel does not represent you unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing now. Your ability to share in any potential future recovery does not depend on serving as lead plaintiff.

View original content to download multimedia:https://www.prnewswire.com/news-releases/data-breach-alert-edelson-lechtzin-llp-is-investigating-claims-on-behalf-of-ascension-health-customers-whose-data-may-have-been-compromised-302337976.html

SOURCE Edelson Lechtzin LLP

Continue Reading

Trending